Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

New paper published in Nature Communications from researchers in Respiratory Medicine Unit, NDM Experimental Medicine'

Mucosal-associated invariant T (MAIT) cells are a recently-discovered type of white blood cell which are believed to play an important role in protecting humans, and many other mammals, from infections. They are able to detect minute quantities of vitamin metabolites produced in cells infected with bacteria and yeasts, but so far they have not been shown to protect against a major human disease. In work undertaken at the University of Melbourne, and published in the journal Nature Communications, the team and I have shown that in humans and animals MAIT cells can respond to two strains of Legionella: the bacterium which causes the very serious lung infection, Legionnaire’s disease. Importantly we showed in mice that having MAIT cells improves the chances of survival. For the first time we also showed that this protection against disease could be improved by activating these cells with vitamin metabolites. This could be an exciting new approach to protecting people against serious lung infections.

Find out more (Nature Communications)

Similar stories

Multi-partner 'OpenMind' consortium to develop technology for new generation of neurostimulation devices

General Research

Investigators at the University of Oxford, University of California San Francisco (UCSF), Brown University and the Mayo Clinic have joined forces to develop open-source technology platforms for a new generation of neurostimulation devices that not only provide stimulation to the brain but also sense, record, and stream brain activity.

Why we must expand newborn screening

General Research

Professor Laurent Servais of the Department of Paeditrics writes for the Oxford Science Blog on why it is important that we become much more efficient in the diagnosis of treatable conditions and in the treatment of these diseases.

New method for cost-effective genome-wide DNA methylation analysis

General Research

Ludwig Cancer Research team build on its TAPS method to develop an alternative to costly whole-genome sequencing for the detection of DNA methylation.

Azithromycin not effective against COVID-19, trial confirms

Clinical Trials General Research

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.